ABSTRACT
also found that charge display had no impact on orders for imaging. 24, 25 The studies to date have shown significant heterogeneity with respect to study design, unit of randomization (tests, physicians, hospitals), number of tests included, settings (inpatient vs outpatient, academic vs private), the type of charge display (Medicare allowable, charges), and outcomes (charge, volume). 22, 26 Because of this heterogeneity, further studies are needed to define the circumstances under which charge display is effective. 22 Most studies displayed charges for a relatively small number (<50) of tests 11, 13, 15, 27, 28 and have been limited to one group of patients (inpatients or outpatients). Also, most previous studies have been for relatively short periods of time (6 months or less), so the sustainability of the intervention is unknown. In practice, a charge display intervention would most likely be implemented systemwide, display charges for hundreds of tests, cover all patient groups, and remain in place for years. To our knowledge, no study has investigated a pragmatic systemwide implementation for a large number of tests. The main objective of this study was to determine the impact of systemwide implementation of a passive charge display intervention. Based on prior studies, [9] [10] [11] [12] [13] [14] [15] [16] [17] 27, 29 we hypothesized that a systemwide charge display would lead to a reduction in orders for laboratory tests. In addition, to better understand any impact of the charge display, we surveyed a sample of physician residents on their estimates of laboratory charges. Few studies have assessed physicians' knowledge of laboratory charges alongside a passive charge display intervention. One study showed an increase in residents' knowledge of costs; however, the increase was seen not only for tests in the intervention but also for tests in the control arm of the study. 30 Thus, clinicians' perception of costs and potential divergence from actual costs may or may not affect effectiveness of the charge display intervention.
Materials and Methods

Setting and Intervention
The study was performed at the University of Utah Health Sciences Center (UUHSC), which includes the University of Utah Health, the University of Utah School of Medicine, and the University of Utah Medical Group. UUHSC serves as the Intermountain West's only academic health care system and includes four hospitals, 10 community clinics, over 10,000 employees, and over 1,200 physicians. The University of Utah hospital is a 527-bed tertiary care hospital. The system orders about 1,700,000 tests per year. Tests were ordered via the computerized provider order entry (CPOE) module of the enterprise electronic health record (EHR) system, Epic (Epic Systems Corporation, Verona, WI). The test menu listed 2,034 tests in 2015. Using data from fiscal year 2014 (July 1, 2013, to June 30, 2014), we ranked tests based on annual charges (annual volume × maximum allowable Medicare reimbursement rate) and formed four strata that represented 68%, 18%, 10%, and 4% of the total annual revenue ❚Table 1❚. We attempted to balance the number of tests and total annual revenue in each stratum. We experimented with a number of cut points and then performed the randomization. Tests in the first three strata were randomly assigned to the active or control arm. Tests in stratum 4 were not randomized because the test volumes were very low. Overall, the tests included in the randomization accounted for 95% of the test volume.
The study was divided into two periods: a baseline period (August 25, 2014, to August 24, 2015) and an intervention period (August 25, 2015, to August 24, 2016) . No charge information was displayed during the baseline period. During the intervention period, charges were displayed for tests in the intervention arm but not in the control arm. A screenshot of the charge display is shown in ❚Figure 1❚. We used the maximum allowable Medicare reimbursement rate (MAMRR) to represent the cost as has been done in several other studies. 11, 23, 27 Although imperfect, the MAMRR was used as a rough cost indicator. The MAMRR is more accurately an indicator of charges. For that reason, we refer to the display of the MAMRR as a charge display rather than a cost display. The design is similar to two recent studies by Feldman et al 11 and Sedrak et al. 23 Like our study, these studies were both controlled trials randomized at the level of tests. Our study differed because the intervention was systemwide and included orders for both inpatients and outpatients. Prior to the intervention, all physicians were notified via email that the MAMRR for some tests would be displayed in Epic.
Resident Survey
Internal medicine and surgery resident physicians were surveyed on their perceptions of charges in June 2015 (presurvey) and April 2016 (postsurvey). Specifically, residents were also asked to estimate the Medicare reimbursement amounts of 14 tests rounded to the nearest whole dollar. Only 14 tests were selected to keep survey fatigue to a minimum. Seven tests had charge displayed in Epic and seven tests did not for the study. The samples of the seven selected for each group (charge display, no charge display) were approximately balanced in terms of annual frequency of orders and MAMRR. The specific tests with charge display were anaerobic culture, blood © American Society for Clinical Pathology AJCP / Original article culture, C-reactive protein, D-dimer, lipase, ova and parasite fecal examination, and urinalysis. The specific tests with no charge display were erythrocyte sedimentation rate-Westergren, hepatic function panel, hepatitis C antibody, Streptococcus (group A) culture, stool culture, thyroxin free, and urine culture. In the postsurvey, residents were also asked if they noticed charges displays in Epic.
Statistical Analysis
We investigated the impact of the intervention using two different methods: (1) regression analysis and (2) interrupted time-series analysis. We used regression analysis to determine the association between the annual volume of each test in year 2 as a function of the annual volume in year 1, the charge of the test (MAMRR), whether charge was displayed, and interactions between the charge, volume, and display:
where V yi is the annual volume of test i in year y, C i is the charge of test i, and D i 2 is an indicator variable showing whether the charge of test i was displayed in year 2. We performed an analogous analysis for annual charges:
where C yi A is the annual revenue associated with test i in year y. For each case, we first analyzed a simple model without interactions and then analyzed a model including interactions. The models were compared using a likelihood ratio (LR) test. Tests with an annual volume of fewer than 50 orders per year were excluded from the regression analysis. We also computed the percent change in volume for each test with a volume of at least 50 orders in the baseline period and compared the distribution of the percent change for tests in the active and control arms. The distributions were compared using the Wilcoxon rank-sum test.
Finally, we used an interrupted time-series (ITS) analysis with a prospective control group: August 24, 2015) . Tests were ranked by annual charge (order volume × maximum Medicare reimbursement rate), and strata were formed from the ranked list. Stratum 1 contained the 53 most charged tests (by annual charge). This stratum contained 3% of the tests, which accounted for 47% of the total annual charge and 55% of the total order volume. Residents were surveyed before (preestimate, n = 110) and after (postestimate, n = 77) charges were displayed. Values are presented as mean (SD) unless otherwise indicated.
❚Figure 1❚ Screenshot. The figure shows how the charge data were displayed in the order entry screen in the Epic electronic health system. CMS rate is the maximum allowable Medicare reimbursement rate. ©2017 Epic Systems Corporation. Used with permission.
variable that represents the period (0 = baseline, 1 = intervention period). Z is a dummy variable for the study arm (0 = control, 1 = active). ITS analysis calculates best-fit lines for the control and active arms in baseline and intervention periods (a total of four lines) and determines whether the intervention was associated with a change in level or slope relative to the control arm. This method, combined with randomized assignment, controls for selection bias and confounding due to maturation and period effects. 31 In the baseline analysis, we performed ITS analysis using all test orders. We also performed two subgroup analyses based on patient location (inpatient vs outpatient) and insurance status (commercial, Medicare/Medicaid, or none).
For the resident survey, data accuracy in charges was computed by subtracting actual MAMRR from estimated charges, and these values were averaged for the seven tests with charge display and the seven tests with no charge display for each resident. Positive values indicate overestimation and negative values indicate underestimation of the test charge. Average accuracy in estimation values was compared with a Wilcoxon signed-rank test to see if residents were better at estimating charges for those tests that had the charge provided in Epic. Average accuracy in estimation values for charge display tests was also compared between residents who answered yes and residents who answered no to the survey item about charge displays in Epic with a Mann-Whitney U test. Since the sample of residents who completed the pre-and postsurveys was slightly different due to the training year ending in June and since we could not link up all pre-and postdata, we did not compare pre-and postaccuracy in estimation values.
We used linear regression to assess associations between actual costs, MAMRR, and listed charges.
All analyses were performed using Stata/IC software, version 14.2 (StataCorp, College Station, TX). ITS analysis was performed using the itsa command as implemented in Stata. 32 The charge display study was deemed exempt (IRB_00082153) and the surveying of residents was deemed non-human subjects research (IRB_00083838) by the University of Utah School Institutional Review Board.
Results
Test Order Characteristics
The total testing volume was 1,635,156 tests in period 1 and 1,953,999 tests in period 2. Fifty-eight percent of test orders originated from outpatients, 36% from inpatients, and 7% from the emergency department. Insurance coverage was evenly divided between commercial (48%) and government (45%) insurance. Six percent of orders were from uninsured patients. A total of 293 (56%) of 521 tests were randomly assigned to the control arm ❚Table 2❚. Tests assigned to the control arm accounted for 75% of the annual charges and 80% of the annual order volume for the tests included in the study (strata 1, 2, and 3).
Association Between Costs, MAMRR, and Listed Charges
We found a statistically significant association (t = 18.8, P < .001, R 2 = 0.22) between actual costs and MAMRR, between listed price and MAMRR (t = 76.6, P < .001, R 2 = 0.82), and between actual costs and listed prices (t = 19.7, P < .001, R 2 = 0.23).
Impact of Charge Display on Order Patterns
The median percent increase in order volume for tests in the control arm was 18.7% (IQR, -0.9% to 36.4%). The distribution of the percentage change in volume is shown in ❚Figure 2❚. The median percent change in volume in the active arm was 14.7% (IQR, -0.9% to 33.2%). There was no significant difference in the distributions (Wilcoxon rank-sum test, z = -0.88, P = .38). The median percent change in annual charge was identical because the displayed MAMRR was constant over both periods.
In a simple regression analysis without interactions, charge display was not significantly associated with a change in volume (P = .71, model 1A, ❚Table 3❚). When interactions were included, charge display had a significant interaction with volume (P = .01, model 1B, Table  3 ). Display was associated with a 7% decrease per 1,000 tests. Thus, charge display would result in approximately 35 fewer orders for tests around the median order volume (477 orders). Overall, the model with interactions provided a better fit than the model without (LR χ 2 3 = 100.9, P < .001). Similarly, a simple analysis (no interactions) showed that annual charge was not significantly associated with charge display (P = .95, model 2A, Table 3 ). A model with interactions showed that the charge-volume interaction was significant (P < .001, model 2B, Table 3 ) with an effect size of 0.0006. The full model (model 2B, Table  3 ) for annual charge produced a better fit than the simple model (model 2A, Table 3 , LR χ 2 3 = 26.6, P < .001). Using ITS analysis, we found that both charge and volume showed an increasing trend over time ❚Figure 3❚; however, the intervention was not associated with a significant change in level or trend ❚Table 4❚. The rate of growth of the order volume decreased nonsignificantly by 600 tests per month (t = -1.09, P = .28) following the intervention and the level decreased nonsignificantly by 2,260 units (t = -.43, P = .67). The growth in total charge increased nonsignificantly by $9,300 per month (t = 0.10, P = .92) and the level decreased nonsignificantly by $9,510 (t = -0.90, P = .38). Subgroup analysis found that charge display was not associated with a significant change in level or trend among inpatients, outpatients, or patients with different types of insurance coverage (Table 4) .
Charge Awareness Among Residents
Residents who started the survey but did not provide an estimate for all 14 tests were omitted from the response rates and other analyses (n = 14 presurvey, n = 20 postsurvey). Seventy-four percent of residents responded to the presurvey (110/149), and 52% responded to the postsurvey (77/149) and had complete data. Response rates for internal medicine were 80% (90/113) presurvey and 54% (61/113) postsurvey. Responses rates for surgery were 56% (20/36) presurvey and 44% (16/36) postsurvey.
❚Table 5❚ provides residents' charge estimates of 14 tests prior to the study and 6 months into the study. Table 5 illustrates that all charge estimates by residents were higher compared with actual Medicare reimbursement amounts. On the presurvey, residents' mean (SD) accuracy in estimates was $53 ($45) for tests with no display and $53 ($50) for tests with display. On the postsurvey, residents' mean (SD) accuracy in estimates was not significantly different for tests with no display ($47 [$36] over actual MAMRR) compared with tests with charge display ($48 [$41], over actual MAMRR), P = .450.
Only 35% of the respondents 27 indicated that they noticed charges were displayed in Epic for particular laboratory tests in the past 6 months, with the other 65% either not noticing the display (48) or not providing a response to this item (n = 2). Mean (SD) estimates in accuracy were $38 ($31) over actual MAMRR for tests with charge display in Epic for the 27 residents who noticed the charge display, but due to large standard deviations, this value was not significantly less than the estimate for the 48 residents who did not notice the charge display ($54 [$45] over actual MAMRR), P = .074.
Discussion
We found that a broad systemwide application of passive charge display had little impact on laboratory test utilization at our institution. Furthermore, there was no evidence that results were affected by annual test volume or test charge. We also tested the impact of charge display in different sets of patients and found no significant effect in different types of patients (inpatient, outpatient) or in patients with different insurance status. We found that residents generally overestimated charges regardless of seeing the charge display, with many of them reporting they did not notice the charge display.
Our study adds to the growing literature on the impact of passive charge display on laboratory utilization. A recent systematic review identified 19 studies on the impact of passive charge display on order patterns for laboratory tests, imaging, and medications. 22 The review identified 12 studies that investigated the impact of charge display on laboratory test utilization. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] 27, 29 Most studies (eight of 12) showed a statistically significant reduction in order volume or charges. The average reduction in charge or volume was approximately 15%. All studies showed at least some benefit. Thus, our results appear unusual because we found no effect. However, a recent study by Sedrak et al, 23 published since the review, found that charge display had no effect. The Sedrak study was similar to ours because the study covered a large proportion of the available tests and was conducted over 2 years.
One potential reason for our observed finding compared with the majority of the prior literature is publication bias, in which authors were more likely to publish studies with a positive result. Another potential is that except for a single email regarding the system update by the chief medical information officer, there were no further attempts to raise awareness of the charge display. While we took this approach to see if a low-charge, "typical" rollout of this type of an information technology system change would have the intended impact, our surveys indicate that the users generally ignored the information, with only 36% noting that they were aware of the charge data being available and with residents being less accurate in their charge estimates for laboratory tests with charges displayed. The survey results provide another possible explanation. Most residents thought the charges of tests were much greater than they actually are in terms of Medicare allowable expense, such that knowing the charges may have had no inhibitory effect on ordering. Although these findings might explain why charge display had little impact on test-ordering behavior, it does not explain why the results obtained at our institution differ from the results obtained elsewhere. Although relatively few studies have been conducted on cost awareness, the existing literature indicates that physicians and residents have poor cost awareness. 21, 30 It is also possible that our institution has unique features that reduced the effect of the intervention. For example, our institution established a program called Value Driven Outcomes (VDO) that facilitates value initiatives throughout the institution. 33, 34 The existence of this program may have created a value-based culture that led to a reduction in unnecessary testing prior to the charge display study. More specifically, the internal medicine department initiated a program to train residents in value-based test ordering. 35 This program was implemented before our study and led to significant reductions in test utilization. These programs may have reduced the potential for further improvement and, as a consequence, limited the impact of charge display at our institution. Our study differed from most prior studies in that we displayed charge information for a large number (n = 254) of tests. Most previous studies displayed charges for a relatively small number of tests. It is possible that displaying the charges of a select number of tests alters behavior because it sends a signal that the institution is particularly interested in the charges associated with a selected set of tests. In contrast, displaying all charges may have less impact. We are aware of two studies that included all tests. Bates et al 16 studied the impact of charge display on medical and surgical inpatients. They observed a 4.2% decrease, which was not statistically significant. Tierney et al 17 observed a 14% decrease (P = .005) in an outpatient population. One might expect charge display to have a greater impact on outpatient orders because tests may be more discretionary. For example, Hampers et al 15 found a greater reduction in test orders in nonadmitted patients when charges were displayed in a pediatric emergency department. We found that charge display had no effect on orders for inpatients or outpatients. Further studies are required to determine how context affects the impact of charge display.
Order processes differ by patient type. Inpatient orders are primarily placed by residents. Residents at our institution receive training on value-based laboratory orders. 35 Outpatient orders are typically placed by staff assistants for faculty. The staff assistants are only concerned with carrying out the faculty's instructions and are not concerned with costs. Thus, we expected that inpatient orders might be more sensitive to charge display. We found that charge display had no impact in either group.
The objective of our study was to determine whether display of a "cost indicator" would affect order behavior. There are several different alternatives for a cost indicator. These include actual costs, the MAMRR, listed charges, or a categorical signal (such as used in restaurant guides). Although actual costs would be the best choice, most organizations are reluctant to reveal their costs. In addition, many laboratories lack good cost accounting data. Thus, it is generally impractical to display actual costs. Charges provide another alternative, but actual charges vary for each patient depending on insurance and can vary significantly from costs. Recent studies have shown that prices for common tests vary by a factor of 10. 36, 37 The variation in charges might be eliminated by using charge categories (eg, $, $$, $$$, $$$$); however, categorization of variables is poor statistical practice because it results in loss of information. 38 Thus, we elected to use the MAMRR as a "cost indicator." The MAMRR has been used in several other studies on the impact of charge display. 11, 23, 24, 27 We recognize that the MAMRR is an imperfect cost indicator; however, we believe the MAMRR is suitable for our objectives. Our objective was not to estimate absolute cost savings. Rather, our objective was to study the impact of a cost indicator on order behavior. Tests at our hospital are performed by ARUP Laboratories (which is wholly owned by the University of Utah). Consequently, we have comprehensive cost accounting data. We showed that, at out institution, the MAMRR is significantly associated with both costs and listed prices. Thus, the MAMRR provides an imperfect but reasonable indication of relative costs to ordering clinicians and can therefore be used to study the impact of a cost indicator on ordering behavior. We would use the actual costs to estimate absolute costs savings, but that was not an objective of our study.
Our study has several limitations. Our results were obtained in a single institution. A multicenter cluster randomized controlled trail would be a stronger study design. Contamination is another potential limitation. We randomized the intervention at the test level. Contamination occurs when items randomized to the control arm receive the intervention. In our study, providers were exposed to charges from some tests but not for others. Seeing charges for some tests could have signaled that the institution was concerned about costs (particularly in the context of the VDO program), and as a result, providers modified their ordering behavior for all tests, not just for those with the charge displayed. A cluster randomized design would eliminate contamination. 39 Our charge display intervention was not accompanied by any concurrent programs. Charge display may be more effective if it had been supported by other programs such as education and audit and feedback. In general, combined interventions are more likely to be effective. 8 The fact that only 36% of residents noticed the charge display suggests that a program to increase awareness would have been helpful. On the other hand, such a program would have complicated the study, and it would not have been possible to isolate the impact of the charge display.
Our study also has some strengths. Our study covered 97% of the available tests and provides a test of a systemwide policy of charge display for laboratory tests. Most prior studies examined relatively few tests or only studied a subset of patients (eg, inpatients). Our study was also conducted over a longer period than most previous studies. Our study was a randomized controlled trial with a pre-post design. This design reduced threats due to selection bias and provided a good counterfactual. The interrupted time-series analysis helped to protect against internal threats to bias such as maturation © American Society for Clinical Pathology AJCP / Original article effects (eg, test volume growth) and period effects (eg, new resident cohort in July). We also conducted a survey to obtain information that might help explain results. Although other studies have examined cost awareness, to our knowledge, none have combined a survey with the intervention to ensure the expected outcomes match the reality of physician perception. 21, 30 In conclusion, we found that charge display had no significant impact on order behavior at our institution. Research on charge display has shown considerable variation in outcomes. This variation suggests that the benefits of charge display depend on additional factors such as supportive interventions (eg, education, audit and feedback) or context (eg, prior utilization efforts). Further research is required to identify the conditions that maximize the benefit of charge display. 
